Coronary microvascular disease: current concepts of pathophysiology, diagnosis and management
Authors:
- 16 July 2020
- journal article
- review article
- Published by Wolters Kluwer Health in Cardiovascular Endocrinology & Metabolism
- Vol. 10 (1) , 22-30
Abstract
Coronary microvascular disease (CMD) is present in 30% of patients with angina and is associated with increased morbidity and mortality. We now have an improved understanding of the pathophysiology of CMD and the invasive and noninvasive tests that can be used to make the diagnosis. Recent studies have shown that management of CMD guided by physiological testing yields better results than empirical treatment. Despite major advances in diagnosing and stratifying this condition, therapeutic strategies remain limited and poorly defined. This review article discusses recent advances in understanding the pathophysiology of CMD, the modalities that are available to diagnose it clinically, current management options and a look at what is in store for the future.Keywords
This publication has 55 references indexed in Scilit:
- Coronary Vasomotor Response to Intracoronary Acetylcholine Injection, Clinical Features, and Long‐term Prognosis in 873 Consecutive Patients With Coronary Spasm: Analysis of a Single‐Center Study Over 20 YearsJournal of the American Heart Association, 2013
- Microvascular Coronary Artery Spasm Presents Distinctive Clinical Features With Endothelial Dysfunction as Nonobstructive Coronary Artery DiseaseJournal of the American Heart Association, 2012
- Safety of Coronary Reactivity Testing in Women With No Obstructive Coronary Artery DiseaseJACC: Cardiovascular Interventions, 2012
- In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE)American Heart Journal, 2011
- Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular eventsEuropean Heart Journal, 2011
- Long-Term Administration of Endothelin Receptor Antagonist Improves Coronary Endothelial Function in Patients With Early AtherosclerosisCirculation, 2010
- Coronary Microvascular Reactivity to Adenosine Predicts Adverse Outcome in Women Evaluated for Suspected IschemiaJACC, 2010
- Light cigarette smoking impairs coronary microvascular functions as severely as smoking regular cigarettesHeart, 2007
- Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathyHeart, 2006
- “Microvascular angina” as a cause of chest pain with angiographically normal coronary arteriesThe American Journal of Cardiology, 1988